Carregant...

Trypanosoma brucei CTP synthetase: A target for the treatment of African sleeping sickness

The drugs in clinical use against African sleeping sickness are toxic, costly, or inefficient. We show that Trypanosoma brucei, which causes this disease, has very low levels of CTP, which are due to a limited capacity for de novo synthesis and the lack of salvage pathways. The CTP synthetase inhibi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hofer, Anders, Steverding, Dietmar, Chabes, Andrei, Brun, Reto, Thelander, Lars
Format: Artigo
Idioma:Inglês
Publicat: The National Academy of Sciences 2001
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC33482/
https://ncbi.nlm.nih.gov/pubmed/11353848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.111139498
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!